Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports

The incidence of acute myelogenous leukemia (AML) in patients over 80 years old is >20 times greater than that observed in younger patients. Previously, no standard treatment protocol for elderly patients with AML existed, however the development of hypomethylating agents, including decitabine, h...

Descripción completa

Detalles Bibliográficos
Autores principales: LIN, JIE, ZHU, HONGLI, LI, SUXIA, FAN, HUI, LU, XUECHUN, CHANG, CHENG, GUO, BO, ZHAI, BING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629021/
https://www.ncbi.nlm.nih.gov/pubmed/23599787
http://dx.doi.org/10.3892/ol.2013.1139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629021/
https://www.ncbi.nlm.nih.gov/pubmed/23599787
http://dx.doi.org/10.3892/ol.2013.1139

Ejemplares similares